Manzamine C congeners with modified azacyclic rings: Synthesis and biological evaluation

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 21, 1996, Pages 2565-2570

  Torisawa, Yasuhiro ^a   Hashimoto, Akihiro ^a   Okouchi, Miwa ^a   Iimori, Takamasa ^b   Nagasawa, Mieko ^c   Hino, Tohru ^a   Nakagawa, Masako ^a  

^a CHIBA UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

^c MEIJI SEIKA KAISHA LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; BETA CARBOLINE DERIVATIVE; MACROCYCLIC COMPOUND; MANZAMINE C; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG RESISTANCE; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; TUMOR CELL;

ANIMALIA;

EID: 0030571285     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00460-X     Document Type: Article

References (17)

1. 1. (a) Sakai, R.; T. Higa, T.; Jefford, C. W.; Bernardinelli, G. J. Am. Chem. Soc. 1986, 108, 6404-6405;
2. (b) Sakai, R.; Kohmoto, S.; Higa, T.; Jefford, C. W.; Bernardinelli, G. Tetrahedron Lett. 1987, 28, 5493-5496;
3. (c) Ichiba, T.; Sakai, R.; Kohmoto, S.; Sausy, G; Higa, T. ibid. 1988, 29, 3083-3086;
4. (d) Nakamura, H.; Deng, S.; Kobayashi, J.; Ohizumi, Y.; Tomotake, Y.; Matsuzaki, Y.; Hirata, Y. ibid. 1987, 28, 621-624.
5. 2. (a) See for example: Nakagawa, M.; Torisawa, Y.; Hosaka, T.; Tanabe, K.; Da-te, T.; Okamura, K.; Hino, T. Tetrahedron Lett. 1993, 34, 4543-4547 and references cited therein;
6. (b) Baldwin, J. E.; Whitehead, R. C. Tetrahedron Lett. 1992, 33, 2059-2062;
7. (c) Baldwin, J. E.; Clarige, T. G. W.; Heupel, F. A.; Whitehead, R. C. ibid. 1994, 35, 7829-7832.
8. 3. (a) Torisawa, Y.; Hashimoto, A.; Nakagawa, M.; Hino, T. Tetrahedron Lett. 1989, 30, 6549-6550;
9. (b) Torisawa, Y.; Hashimoto, A.; Nakagawa, M.; Seki, H.; Hara, R.; Hino, T. Tetrahedron 1991, 47, 8067-8078.
10. 4. See for example: Ikota, N.; Shioiri, T.; Yamada, S.; Tachibana, S. Chem. Pharm. Bull. 1980, 28, 3347-3356.
11. 5. All new compounds were characterized by full spectroscopic (NMR, IR, high-resolution MS) data ; some of these data have been published previously: (a) Seki, H.; Nakagawa, M.; Hashimoto, A.; Hino, T. Chem. Pharm. Bull. 1993, 41, 1173-1176;
12. (b) Seki, H.; Hashimoto, A.; Hino, T. Chem. Pharm. Bull. 1993, 41, 1169-1172.
13. 3 307.2051, Found 307.2037.
14. 7. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays: Mosman, T. J. Immunol. Methods. 1983, 65, 55-63.
15. 8. A new maytansinoid antibiotic, AI-R2397 II. Antitumor activity: Ishii, S.; Nagasawa, M.; Nakazawa, T.; Yamamoto, H. Sci. Report of Meiji Seika Kaisha (Japan). 1988, 27, 21-26.
16. 9 (formula presented)
17. 10. See for example: Feigon, J.; Denny, W. A.; Leupin, W.; Kearns, D. R. J. Med. Chem. 1984, 27, 450.